Specifications: Typbar TYPBAR, the first vaccine in India to get a WHO GMP Certification, is a highly purified Vi Capsular Polysaccharide New Generation Typhoid vaccine. Bharat Biotech International Limited is the largest primary manufacturer of typhoid vaccine in the country. The Company dedicated the vaccine to Dr. John R. Robbins, Father of Polysaccharide vaccines. Why TYPBAR Produces reactions less than half as frequently as parenteral inactivated whole cell killed vaccine Demonstrated at least a four fold rise in antibody titres i.e. sero protection Virtually devoid of side-effects as it only contains Vi Polysaccharide, the most important bacterial cell wall component that controls the virulence of the Typhoid bacilli Fever and pain producing components such as endotoxins are removed Isolated and purified from S. typhi, a Ty2 strain from NIH , USA One dose as compared to two doses of older generation vaccines Successful multicentric double blind clinical trials conducted in patients across the country TYPBAR is available as a fluid preparation. Single dose 0.5 ml. Multidose 2.5 ml. One injection offers immunity for three years. Booster vaccination will afford immunity against Typhoid for life.